Literature DB >> 26944073

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

André Lechel1, Angélique Gougelet2.   

Abstract

Entities:  

Keywords:  HEPATOCELLULAR CARCINOMA; INFLAMMATORY MEDIATORS

Mesh：

Substances：

Year:  2016        PMID： 26944073     DOI： 10.1136/gutjnl-2016-311446

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  MiR-382 targets GOLM1 to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Authors:  Shukun Zhang; Wenmin Ge; Gangyong Zou; Lin Yu; Yongcun Zhu; Qiujing Li; Yujie Zhang; Zhanli Wang; Tao Xu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

2.  Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma.

Authors:  Shao-Geng Zhang; Yu-Feng Li; Na-Na Zhao; Cheng-Cai Lai; Si-Jie Cheng; Jin Yan; Peirui Zhang; Zhaohai Wang; Xi-Liang Wang; Peng-Hui Yang
Journal:  Oncol Lett       Date:  2017-08-18       Impact factor: 2.967

3.  Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.

Authors:  Liman Qiu; Yanbing Huang; Zhenli Li; Xiuqing Dong; Geng Chen; Haipo Xu; Yongyi Zeng; Zhixiong Cai; Xiaolong Liu; Jingfeng Liu
Journal:  Mol Oncol       Date:  2019-01-09       Impact factor: 6.603

4.  Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model.

Authors:  Alessandra Tessitore; Valentina Mastroiaco; Antonella Vetuschi; Roberta Sferra; Simona Pompili; Germana Cicciarelli; Remo Barnabei; Daria Capece; Francesca Zazzeroni; Carlo Capalbo; Edoardo Alesse
Journal:  Oncotarget       Date:  2017-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.